Obstructive nephropathy in the pig aspects of renal hemodynamics and hormonal changes during acute unilateral ureteral obstruction

APMIS, Supplement

Volumn 106, Issue 82, 1998, Pages 7-48

  Frøkiær, Jørgen ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDOMETACIN; HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; GLOMERULUS FILTRATION RATE; HORMONAL REGULATION; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SWINE; URETER OBSTRUCTION; ACUTE DISEASE; ANIMAL; DISEASE MODEL; HEMODYNAMICS; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ACUTE DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; HEMODYNAMIC PROCESSES; HORMONES; KIDNEY; SWINE; URETERAL OBSTRUCTION;

EID: 0031725501     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (259)

1. Rosendahl H. Ultrasound screening for fetal urinary tract malformations: a prospective study in general population. Eur J Obst Gyn Reprod Biol 1990;36:27-33.
2. Klahr S. Pathophysiology of obstructive nephropathy: A1991 update. Seminars in Nephrology 1991;11(2):156-68.
3. Bell ET. Renal diseases. Philadelphia: Lea & Fibiger; 1947;Obstruction of the urinary tract-hydronephrosis. p. 113-39.
4. Dorlands Illustrated Medical Dictionary. 25th Edition. Philadelphia, USA: WB Saunders. 1974;
5. Whitaker RH. Methods for assessing obstruction in dilated ureters. Br J Urol 1973;45:15-22.
6. O'Reilly PH, Testa HJ, Lawson RS, Farrar DJ, Charlton Edwards E. Diuresis renography in equivocal urinary tract obstruction in dilated ureters. Br J Urol 1978;50:76-80.
7. Whitfield HN, Britton KE, Hendry WF.Wickham JEA. Furosemide intravenous urograpny in the diagnosis of pelviureteric junction obstruction. Br J Urol 1979;51:445-8.
8. Britton KE,Whitfield HN, Nimmon CC, Hendry WF. Obstructive nephropathy: Successful evaluation with radionuclides. Lancet 1979;905-7.
9. Djurhuus JC, Sorensen SS, Jorgensen TM, TagehojJensen F. Predictive value of pressure flow studies for the functional outcome of reconstructive surgery for hydronephrosis. Br J Urol 1985;57:6-9.
10. Poulsen EU, Frokir J, Tagehoj-Jensen F, Jorgensen TM, Norgaard JP, Hedegaard M, Djurhuus JC. Diuresis renography and simultaneous renal pelvic pressure in hydronephrosis. Journal of Urology 1987;138:272-5.
11. Koff SA. Problematic ureteropelvic junction obstruction. J Urol 1987;138:390-5.
12. Koff SA, Peller PA,Young DC, Pollifrone DL. The assessment of obstruction in the newborn with unilateral hydronephrosis by measuring the size of the opposite kidney. J Urol 1994; 152:596-9.
13. KoffSA, Campbell K. Nonoperative management of unilateral neonatal hydronephrosis. J Urol 1992; 148:525-31.
14. Bratt CG, Aurell M, Nilsson S. Renal function in patients with hydronephrosis. Br J Urol 1977;49:249-55.
15. Samuelson U, Granerus G, Bjures J, Hagberg S, Hjälmas K. Renal function in idiopathic hydronephrosis in children. Follow-up after conservative and surgical treatment. Scand J Urol Nephrol 1984;18:135-41.
16. Peters CA. Urinary tract obstruction in children. J Urol 1995;154:1874-84.
17. Gillenwater JY Walsh PC, Retik AB, Stamey TA, Vaughan ED, Jr. editors. Campbells Urology. 6th ed. Philadelphia, USA: WB Saunders; 1992; 11, Pathophysiology of urinary tract obstruction, p. 499-532.
18. Bradley SE, Andersen DL. Renal function in man during acute hydronephrosis. Bull School Med Univ Maryland 1956;41:39-45.
19. Yarger WE, Harris RH. Seldin DW, Giebisch G, editors. The Kidney: Physiology and Pathophysiology. New York, USA: Raven Press; 1985; 84, Urinary tract obstruction, p. 1963-78.
20. Vaughan ED, Jr., Shenasky JH, Gillenwater JY Mechanism of acute hemodynamic response to ureteral occlusion. Invest Urol 1971;9:109-18.
21. Moody TE, Vaughan ED, Jr., Gillenwater J Y. Relationship between renal blood flow and ureteral pressure during 18 hours of total unilateral ureteral occlusion. Invest Urol 1975; 13:246-51.
22. Suki WN, Guthrie AG, Martinez-Maldonado M, Elnoyan G. Effects of ureteral pressure elevation on renal hemodynamics and urine concentration. Am J Physiol 1971;220(l):38-43.
23. Vaughan ED, Jr., Sorenson EJ, Gillenwater JY The renal hemodynamic response to chronic unilateral complete ureteral occlusion. Invest Urol 1970;9(1):78-90.
24. Djurhuus JC, Nerstrom B, Gyrd-Hansen N, Rask-Andersen H. Experimental hydronephrosis. an electrophysiologic investigation before and after release of obstruction. Acta Chir Scand 1976;472(Suppl.):17-28.
25. Mortensen J, Djurhuus JC, Moller JCF, Laursen H,Tagehoj-Jensen F. The pressure volume relationship of the renal pelvis in total obstruction in pigs. Urol Res 1983;ll:251-3.
26. Frokir J.Taagehoj- Jensen F, Husted SE, Mortensen J, Djurhuus JC. Pelvic pressure measurements in the totally obstructed pyeloureter of the pig in 4 weeks. Urol Int 1988;43(l):16-8.
27. Frokir J, Tagehoj-Jensen F, Husted SE, Mortensen J, Djurhuus JC. Renal blood flow and pelvic pressure after 4 weeks of total upper urinary tract obstruction in the pig. The effect of aTxA2 synthetase inhibitor on active preglomerular vasoconstriction. Urol Res 1988;16(3):167-71.
28. Huland H, Leichtweiss H-P, Augustin HJ. Changes in renal hemodynamics in experimental hydronephrosis. Invest Urol 1980;18(4):274-77.
29. Huland H, Leichtweiss H-P, Schröder H, Jeschkies J. Effects of ureteral obstruction on renal cortical blood flow. Urol Int 1982;37:213-9.
30. Harris RH, Gill JM. Changes in glomerular filtration rate during complete ureteral obstruction in rats. Kidney Int 1981 ;19:603-8.
31. Provoost AP, Molenaar JC. Renal function during and after a temporary complete unilateral ureter obstruction in rats. Invest Urol 1981;18(4):242-46.
32. Harris RH.Yarger WE. Renal function after release of unilateral ureteral obstruction in rats. Am J Physiol 1974;227(4):806-15.
33. Navar LG, Baer PG. Renal autoregulatory and glomerular filtration responses to gradated ureteral obstruction. Nephron 1970;7:301-16.
34. Vaughan ED, Jr., Sweet RC, Gillenwater J Y Peripheral renin and blood pressure changes following complete unilateral ureteral occlusion. J Urol 1970; 104:89-92.
35. Chevalier RL, Gomez RA. Response of the renin-angiotensin system to relief of neonatal ureteral obstruction. Am J Physiol 1988;255:F1070-7.
36. El-Dahr SS, Gomez RA, Gray MS, Peach MJ, Carey RM, Chevalier RL. In situ localization of renin and its mRNA in neonatal ureteral obstruction. Am J Physiol 1990;258:F854-62.
37. Eide I, Loyning E, Langard O, Kiil F. Mechanism of renin release during acute ureteral constriction in dogs. CircRes 1977;40(3):293-99.
38. Olsen UB, Magnussen MP, Eilertsen E. Prostaglandins, a link between renal hydro- and hemodynamic in dogs. Acta Physiol Scand 1976;97:369-76.
39. Kawasaki A, Needleman P. Contribution of thromboxane to renal resistance changes in the isolated perfused hydronephrotic rabbit kidney. Circ Res 1982;50:48690.
40. Purkerson ML, Klahr S. Prior inhibition of vasoconstrictors normalizes GFR in postobstructed kidneys. Kidney Int 1989;35:1306-14.
41. Klotman PE, Smith SR.Volpp BD, CoffmanTM.Yarger WE. Thromboxane synthetase inhibition improves function of hydronephrotic rat kidneys. Am J Physiol 1986;250:F282-7.
42. Balint P, Laszlo K. Effect of imidazole and indomethacin on hemodynamics of the obstructed canine kidney. Kidney Int 1985;27:892-7.
43. Marin Grez M, Fleming JT, Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature 1986;324(6096):473-6.
44. Harris PJ, Thomas D, Morgan TO. Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption. Nature 1987;326(6114):697-8.
45. Showalter CJ, Zimmerman RS, Schwab TR, Edwards BS, OpgenorthTJ, Burnett JC, Jr. Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II. Am J Physiol 1988;254(3):R453-6.
46. Reyes AA, Porras BH, Chasalow FI, Klahr S. L-arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis. Kidney Int 1994;45:1346-54.
47. Reyes A A, Klahr S. Renal function after release of ureteral obstruction: Role of endothelin and the renal artery endothelium. Kidney Int 1992;42:632-8.
48. Chevalier RL.Thornhill BA, Gomez RA. EDRF modulates renal hemodynamics during unilateral ureteral obstruction in the rat. Kidney Int 1992;42:400-6.
49. Reyes A A, Lefkowith J, Pippin J, Klahr S. Role of the 5lipooxygenase pathway in obstructive nephropathy. Kidney Int 1992;41:100-6.
50. Felsen D, Loo MH, Marion DN,Vaughan ED, Jr. Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction. J Urol 1990; 144:141-5.
51. Shirley DG.Walter SJ. Acute and chronic changes in renal function following unilateral nephrectomy. Kidney Int 1991;40:62-8.
52. Kopp UC, DiBona GF. Brenner BM, editor. Brenner and Rector's The Kidney. 5th ed. Philadelphia, USA: WB Saunders; 1995; 19, Effects of renal nerves and neurotransmitters on renal function, p. 789-814.
53. El-Dahr SS, Gomez RA, Gray MS, Peach MJ, Carey RM, Chevalier RL. Renal nerves modulate renin gene expression in the developing rat kidney with ureteral obstruction. J Clin Invest 1991;87:800-10.
54. MoodyTE.Vaughan ED, Jr.,WykerAT, Gillenwater JY. The role of intrarenal angiotensin II in the hemody-namic response to unilateral obstructive uropathy. Invest Urol 1977;14(5):390-97.
55. Huland H, Leichtweiss H-P, Augustin HJ. Effect of angiotensin II antagonist, alfa-receptor blockage, and denervation on blood flow reduction in experimental, chronic hydronephrosis. Invest Urol 1980; 18:203-6.
56. Chevalier RL, Peach MJ. Hemodynamic effects of enalapril on neonatal chronic partial ureteral obstruction. Kidney Int 1985;28:891-8.
57. Yarger WE, Schocken DD, Harris RH. Obstructive nephropathy in the rat. J Clin Invest 1980;65:400-12.
58. Vaughan ED, Jr. Rajfer J, editor. Urologie Endocrinology. Philadelphia, USA: WB. Saunders; 1986; 5, Renal hypertension, p. 138-52.
59. Yanagisawa H, Morrissey J, Morrison AR, Klahr S. Eicosanoid production by isolated glomeruli of rats with unilateral ureteral obstruction. Kidney Int 1990;37:1528-35.
60. 60: Himmelstein SI, CoffmanTM, Yarger WE, Klotmann PE. Atrial natriuretic peptide-induced changes in renal prostacyclin production in ureteral obstruction. Am J Physiol 1990;258:F281-6.
61. Harris PJ, Skinner SL. Intra-renal interactions between angiotensin II and atrial natriuretic factor. Kidney Int 1990;38,Suppl. 30:887-91.
62. Purkerson ML, Blaine EH, Stokes TJ, Klahr S. Role of atrial peptide in the natriuresis and diuresis that follows relief of obstruction in rat. Am J Physiol 1989;256:F5839.
63. Terns JM.Tumbleson ME, editor. Swine in Biomedical Research. New York and London: Plenum Press; 1986; Swine as a model in renal physiology and nephrology: An overview, p. 1673-709.
64. Nielsen TW, Maaske CA, Booth NH. Bustad LK, McClellan RO, editors. Swine in Biomedical Research. Seattle: Frayn; 1965; Some comparative aspects of porcine renal function, p. 529-37.
65. Djurhuus JC. Aspects of renal pelvic function 1980; Thesis, Borns Bogtrykkeri, Copenhagen.
66. Becker BA, Ford JJ, Nienaber JA, Hahn GL, Christenson RK. Tumbleson ME, editors.Swine in Biomedical Research. New York and London: Plenum Press; 1986; Endocrine and behaviour changes associated with intensive housing systems for swine, p. 173-89.
67. Stone AM, Stahl WM. Renal effects of hemorrhage in normal man. Ann Surg 1970; 172:825-36.
68. Maier M, Starlinger m, Zhegu Z, Rana H, Binder BR. Effect of the protease inhibitor aprotinin on renal hemodynamics in the pig. Hypertension 1985;7:32-8.
69. Sirinek KR, Hura CE. Mattox, Moore, and Felain, editors. Trauma. Appleton and Lange; 1988; 58, Renal Failure, p. 835-48.
70. Sondeen JL, Gonzaludo GA, Loveday JA, Deshon GE, Clifford CB, Hunt MM, Rodkey WG,Wade CE. Renal responses to graded hemorrhage in conscious pig. Am J Physiol 1990;259:R119-25.
71. Sjödin JG, Häggmark S, Reiz S. Effects of indomethacin on central, renal and coronary hemodynamics. Scand J Urol Nephrol 1983; 17:73-9.
72. Seikurt EE. Effect of ureteral blockade on renal blood flow and urinary concentration ability. Am J Physiol 1963;205(2):286-92.
73. Nash FD, Seikurt EE. Effects of elevated ureteral pressure on renal blood flow. Circ Res 1964;XIV & XV (SupplI):I-142-7.
74. Siegel NJ, Feldman RA, Lytton B, Hayslett JP, Kashgarian M. Renal cortical blood flow distribution in obstructive nephropathy in rats. Circ Res 1977;40(4):37984.
75. AbeY, KashimotoT.Yamamoto K, Ueda J. Intrarenal distribution of blood flow during ureteral and venous pressure elevation. Am J Physiol 1973;224(4):746-51.
76. Bay WH, Stein JH, Rector JB, Osgood RVV, Ferns TF. Redistribution of renal cortical blood flow during elevated ureteral pressure. Am J Physiol 1972;222(l):33-7.
77. Yarger WE, Griffith LD. Intrarenal hemodynamics following chronic unilateral ureteral obstruction in the dog. Am J Physiol 1974;227(4):816-26.
78. Frokiaer J, Hvistendahl JJ, Rehling M. Renal blood flow measured by ultrasound transit time and renal clearance of 125-OIH. In: Radionuclides in Nephrourology. Eds. Taylor A, Nally JV.Thomsen H. Society ofNuclear Medicine, Reston.VA, USA. Pp. 127-130,1997
79. DAlmeida MS, Gaudin C, Lebrec D. Validation of 1and 2-mm transit-time ultrasound flow probes on mesenterec artery of rats. Am J Physiol 1995;268:H1368-72.
80. Lundell A, Bergqvist D, Mattson E, Nilsson B.Volume blood flow measurements with a transit time flowmeter: an in vivo and in vitro variability and validation study. Clin Physiol 1993; 13:547-57.
81. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatric Clinics of North America 1987;34:571-90.
82. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985;28(5):830-8.
83. Schuster VL, Seldin DW Seidin DW, Giebisch G, editors. The Kidney: Physiology and Pathophysiology. New York: Raven Press; 1985; 18, Renal Clearance, p. 365-95.
84. Pasternack A, Kuhlback B. Diurnal variations of serum and urine creatine and creatinine. Scand J Clin Lab Invest 1971 ;27(l):l-7.
85. Kappelgaard AM, Nielsen MD, Giese J. Measurement of angiotensin II in human plasma: Technical modifications and practical experience. Clinica Chimica Acta 1976;67:299-306.
86. Rask-Madsen J, Brunsgaard A, Munck O, Nielsen MD, Worming H.The significance of bile acids and aldosterone for the electrical hyperpolarization of human rectum in obese patients treated with intestinal by-pass operation. Scand J Gastroenterol 1972;9:417-26.
87. Thomassen AR, Bagger JP, Nielsen TT, Pedersen EB. Atrial natriuretic peptide during pacing in controls and patients with coronary arterial disease. Int J Cardio!1987;17(3):267-79.
88. Pedersen EB, Danielsen H, Spencer ES. Effect of indapamid on renal plasma flow, glomerular filtration rate, and arginine-vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol 1984;26:523-47.
89. Powel WS. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins 1980;20(5):947-57.
90. Thomsen K. Lithium clearance: A new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron 1984;37:217-23.
91. Koomans HA, Boer WH, Mees EJD. Evaluation of lithium clearance as a marker of proximal tubule sodium handling. Kidney Int 1989;3 6:2-12.
92. Boer WH, Fransen R, Shirley DG, Walter SJ, Boer P, Koomans HA. Evaluation of the lithium clearance method: Direct ananlysis of tubular lithium handling bymicropuncture. Kidney Int 1995;47:1023-30.
93. Shirley DG, Walter SJ. Current status of the lithium clearance method for the assessment of renal proximal tubular function. Lithium 1993;4:25-31.
94. Whitaker RH. Diagnosis of obstruction in dilated ureters. Ann Roy Coll Surg Engl 1973;53:153-66.
95. Mortensen J, Djurhuus JC Hydrodynamics of the normal multicalyceal pyeloureter in pigs: The pelvic pressure response to increasing flow rates,its normal ranges and intraindividual variations. J Urol 1985; 133:704-8.
96. Mortensen J. Hydrodynamics of the pyeloureter of the pig. Neurourology and Urodynamics 1986;5(1):87-117.
97. Constantinou CE, Djurhuus JC. Pyeloureteral dynamics in the intact and chronically obstructed multicalyceal kidney. Am J Physiol 1981;241:R398-411.
98. Zimskind PD, Davis DM, Lewis PL, DeCaestecker J, Berwind RT. Complete obstruction of the ureter: Immediate and long term effects on renal pelvic pressure in dogs. Surg Forum 1968; 19:538-40.
99. Constantinou CE. Quantitative evaluation of the biomechanics and electrophysiology of the renal pelvis and ureter during peristalsis. 1973; Stanford University; USA.
100. Djurhuus JC, Nerstrom B, Rask-Andersen H. Dynamics of upper urinary tract in man. Peroperative electrophysiological findings in patients with manifest or suspected hydronephrosis. Acta Chir Scand 1976;472(Suppl.):49-58.
101. Bratt CG, Aurell M, Erlandson B-E, Nilson AE, Nilsson S. Intrapelvic pressure and urinary flow rate in obstructed and nonobstructed human kidneys. J Urol 1982;127(6):1136-42.
102. Kiil F. Pressure recordings in the upper urinary tract. Scand J Clin Lab Invest 1953;5:383-4.
103. Kiil F, Aukland K. Renal concentration mechanism and hemodynamics at increased ureteral pressure during osmotic and saline diuresis. Scand J Clin Lab Invest 1961; 13:276-87.
104. Thomsen HS, Dorph S, Olsen S. Pyelorenal backflow in normal and ischemic rabbit kidneys. Invest Radiol 1981;16(3):206-14.
105. Thomsen HS, Larsen S.Talner LB. Pyelorenal backflow during retrograde pyelography in normal and ischemic porcine kidneys. Eur Urol 1982;8:291-7.
106. Thomsen HS, Talner LB, Higgins CB. Intrarenal backflow during retrograde pyelography with graded intra-pelvic pressure. A radiologie study. Invest Radiol 1982;17(6):593-603.
107. Stenberg A, Bohman S-O, Morsing P, Müller-Suur C, Olsen L, Persson AEG. Back-leak of pelvic urine to the bloodstream. Acta Physiol Scand 1988;134:223-34.
108. lOS.Mortensen J, Djurhuus JC Pyeloureteral dynamics. Renal pelvis pressure-flow relationship in pigs. Neu-rourol Urodyn 1983;2:175-81.
109. Cheng E, Lee C, Decker R, Sensibar JA, Lang S, Kaplan WE, Maizels M, Firlit CF. Captopril inhibits obstructive changes in the neonatal rabbit bladder. J Urol 1996;155:(5)599A.
110. Sullivan MP, Peters CA.Williams GH,Yalla SV, Kifor I. Immunohistochemical and functional evidence of angiotensin II in the fetal sheep bladder. J Urol 1997;157(4):680A.
111. Waldeck K, Lindberg BF, Persson K, Anderson K-E. Dual pathways for angiotensin II formation in the human detrusor. J Urol 1997;157(4):679A.
112. Carmines PK.Tanner GA. Angiotensin in the hemodynamic response to chronic nephron obstruction. Am J Physiol 1983;245:F75-82.
113. MendeIsohn FAO, Millan M, Quirion R, Aguilera G, Chou S, Catt KJ. Localization of angiotensin II receptors in rat and monkey kidney by in vitro autoradiography. Kidney Int 1987;31:S40-4.
114. Mitchell KD, Navar LG. Interactive effects of angiotensin II on renal hemodynamics and tubular reabsorptive function. Kidney Int 1990;38, Suppl. 30:S69-73.
115. Lohmeier TE, Cowley AW, Jr.,Trippodo NC, Hall JE, Guyton AC. Effects of endogenous angiotensin II on renal sodium excretion and renal hemodynamics. Am J Physiol 1977;233(5):F388-95.
116. Rosenkilde-Olsen P. The urodynamic patterns and pathophysiology of the canine allotransplanted upper urinary tract. Scand J Urol Nephrol 1981;15(3)303-8.
117. Djurhuus JC, Sakso P, Mortensen J. The pressure-volume relationship of the pig renal pelvis. J Urol 1986;135(3):648-51.
118. Alien JT.Vaughan ED, Jr., Gillenwater JYThe effect of indomethacin on renal blood flow and ureteral pressure in unilateral ureteral obstruction in awake dogs. Invest Urol 1978; 15:324-7.
119. Sjödin JG. Effects of intravenous indomethacin during acute ureteral obstruction. Scand J Urol Nephrol 1981 ;SuppL 66:1-43.
120. Grenabo L, Aurell M, Delin K, Holmlund D, Sjödin JG. Antidiuretic hormone levels and the effect of indomethacin on ureteral colic. J Urol 1983; 129:941-3.
121. Holmlund D, Sjödin J-G. Treatment of ureteral colic with intravenous indomethacin. J UroU978; 120:676-7.
122. Jönsson P-E, Olsson AM, Petersson B-A, Johansson K. Intravenous indomethacin and oxycone-papaverine in the treatment of acute renal colic. A double-blind study. Br J Urol 1987;59:396-400.
123. Flannigan GM, Clifford RFC, Carver RA, Yule AG, Madden NP.Towler JM. Indomethacin-an alternative to pethidine in ureteric colic. Br J Urol 1983;55:6-9.
124. Sjödin JG, Wahlberg J, Persson AEG. The effect of indomethacin on glomerular capillary pressure and pel-vie pressure during ureteral obstruction. J Urol 1982; 127:1017-20.
125. Cole RS, Fry CH, Shuttleworth KED. The actions of prostaglandins on isolated human ureteric smooth muscle. Br J Urol 1988;61:19-26.
126. Lundstam S, Jonsson O, Kihl B, Pettersson S. Prostaglandin synthetase inhibition of renal pelvic smooth muscle in the rabbit. Br J Urol 1985;57:390-3.
127. KimotoY, Constantinou CE. Regional effects of indomethacin, acetylsalicylic acid and SC-19220 on the contractility of rabbit renal pelvis (pacemaker regions and pelviureteric junction). J Urol 1991;146:433-8.
128. Angelo-Khattar M.Thulesius O, NilssonT, CherianT, Joseph L. Motitlity of the human ureter, with special reference to the effect of indomethacin. Scand J Urol Nephrol 1985; 19:261-5.
129. Reinking LN.Veale MC. Mechanical stimulation of renal pelvic wall peristalsis in the rat. Experientia ' 1984;40:540-1.
130. Arendshorst WJ, Finn WF, Gottschalk CW Nephron stop-flow pressure response to obstruction for 24 hours in the rat kidney. J Clin Invest 1974;53:1497-500.
131. Hsu CH, KurtzTW, Rosenzweig J,Weller JM. Intrarenal hemodynamics and ureteral pressure during ureteral obstruction. Invest Urol 1977;14(6):442-5.
132. DiBona GF. Effect of mannitol diuresis and ureteral occlusion on distal tubular reabsorption. Am J Physiol 1971;221(2):511-4.
133. Suki W, Eknoyan G, Rector FC, Seidin DVV Patterns of nephron perfusion in acute and chronic hydronephrosis. J Clin Invest 1966;45(1):122-31.
134. Oliw E. Acute unilateral ureteral occlusion increases plasma renin activity and contralateral urinary prostaglandin excretion in rabbits. European J Pharmacol 1978;53:95-102.
135. Dal Canton A, Stanziale R, Corradi A, Andreucci VE, Migone L. Effects of acute ureteral obstruction on glomerular hemodynamics in the rat kidney. Kidney Int 1977; 12:403-11.
136. Blantz RC, Können KS, Tucker BJ. Glomerular filtration response to elevated ureteral pressure in both the hydropenic and the plasma-expanded rat. Circulation Research 1975;37:819-29.
137. Dal Canton A, Corradi A, Stanziale R, Maruccio G, Migone L. Effects of 24-hour unilateral ureteral obstruction on glomerular hemodynamics in rat kidney. Kidney Int 1979;15:457-62.
138. Tanner GA. Effects of kidney tubule obstruction glomerular function in rats. Am J Physiol 1979;237(5):F379-85.
139. Shenasky JH, Gillenwater JY, Graham SD.Wooster LD. Effects of vasoactive drugs on renal vascular resistance in obstructive disease. J Urol 1971;106:355-9.
140. Vander AJ, Miller R. Control of renin secretion in the anesthetized dog. Am J Physiol 1964;207(3):537-46.
141. Steinhausen M, Kücherer H, Parekh N, Weis S, Wiegman DL, Wilhelm K-R. Angiotensin II control of the renal microcirculation: Effect of blockade by saralasin. Kidney Int 1986;30:56-61.
142. MimranH, Hinrichs KJ, Hollenberg NK. Characteri-zation of smooth muscle receptors for angiotensin. Am J Physiol 1974;226:185-90.
143. Antonaccio MJ, Cushman D\V Drugs inhibiting the renin angiotensin system. Fed Proc 1981;40:2275-84.
144. McDougal WS. Pharmacologie preservation of renal mass and function in obstructive uropathy. J Urol 1982; 128:418-21.
145. Chevalier RL, Jones CE. Contribution of endogenous vasoactive compounds to renal vascular resistance in neonatal chronic partial ureteral obstruction. J Urol 1986;136:532-5.
146. Katzberg RW, DiMarco PL, Morris TW, Harnish PP, Graves RF, Merguerian PA,Ventura JA, Proskin HM. Role of angiotensin II in renal hemodynamic functions during the initial stages of acute ureteral obstruction. Life Sei 1988;44:1963-71.
147. Vaughan ED, Jr., Marion DA, Felsen D. Evidence against angiotensin II or thromboxane A2 as mediators of the increased renal vascular resistance found following ureteral ureteral occlusion. Kidney Int 1986;30:237A.
148. Blackshear JL.Wathen RL. Effects of indomethacin on renal blood flow and renin secretory responses to ureteral occlusion in the dog. Mineral Electrolyte Metab 1978; 1:271-8.
149. Chikaka I, Brenner BM. Local intrarenal vasoconstrictor-vasodilator interactions in mild partial ureteral obstruction. Am J Physiol 1979;236(2):F131-40.
150. Perlmutter A, Miller L,Trimble L, Marion DA, Vaughan ED, Jr., Felsen D. Toradol, an NSAID used for renal colic, decreases renal perfusion and ureteral pressure in a canine model of unilateral ureteral obstruction. J Urol 1993;149:926-30.
151. Nishikawa K, Morrison A, NeedlemanP. Exaggerated prostaglandin biosynthesis and its influence on renal resistance in the isolated hydronephrotic rabbit kidney. J Clin Invest 1977;59:1143-50.
152. Morrison AR, Moritz H, Needleman P. Mechanism of enhanced renal prostaglandin biosynthesis in ureter obstruction. J Biol Chem 1978;253(22):8210-2.
153. Morrison AR, Nishikawa K, Needleman P.Thromboxane A2 biosynthesis in the ureter obstructed isolated perfused kidney of the rabbit. J Pharmacol Exp Ther 1978;205(l):l-8.
154. Harris RH,Yarger WE. Renal function after release of unilateral ureteral obstruction in rats. Am J Physiol 1974;227(4):806-15.
155. Bander SJ, Buerkert J, Martin D, Klahr S. long-term effects of 24-hr unilateral ureteral obstruction on renal function in the rat. Kidney Int 1985;28:614-20.
156. Vaughan ED, Jr., Sorenson EJ, Gillenwater JY. Alterations in renal function immediately after release of acute total unilateral ureteral occlusion. Invest Urol 1971;8:450-61.
157. Crowley AR, Byrne JC, Vaughan ED, Jr., Marion DN. The effect of acute obstruction on ureteral function. J Urol 1990;143:596-9.
158. Pimentel JL, Jr., Wang S, Martinez-Maldonado M. Regulation of the renal angiotensin II receptor gene in acute unilateral ureteral obstruction. Kidney Int 1994;45:1614-21.
159. Pimentel JL, Jr., Martinez-Maldonado M.Wilcox JN, Wang S, Luo C. Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney Int 1993:44:390-400.
160. Kaneto H, Momssey J, McCracken R, Reyes A A, Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 1994;45:1637-47.
161. Lanzone JA, Gulmi FA, Chou S-Y, Mooppan UMM, Kim H. Renal hemodynamics in acute unilateral ureteral obstruction:Contribution of endothelium-derived relaxing factor. J Urol 1995;153(6):2055-9.
162. Tigerstedt R, Bergman PG. Niere und kreislauf. Skand Arch Physiol 1898;8:223-71.
163. Braun-Menendez E, Fasciolo JC, Leloir LF, Munoz JM. The substance causing renal hypertension. J.Physiol. 1940;98:283-98.
164. Page IH, Helmer OM. A crystalline pressor substance (angiotonin) resultning from the reaction between renin and renin activator. J Exp Med 1940;71:29-42.
165. Williams JR.Wegria R, HarrisonTR. Relation of renal pressor substance to hypertension in hydronephrotic rats. Arch Int Med 1938;62:805-12.
166. Beckwith JR. The effect of the time factor on the amount of pressor material in kidney after unilateral ligation of renal pedicle and after unilateral ligation of ureter. Am J Pysiol 1941;132(l):l-4.
167. El-Dahr SS, Gomez RA, Khare G, Peach MJ, Carey RM, Chevalier RL. Expression of renin and its mRNA in the adult rat kidney with chronic ureteral obstruction. Am J Kid Dis 1990;15(6):575-82.
168. Norwood VF, Carey RM, Geary KM, Jose PA, Gomez RA, Chevalier RL. Neonatal ureteral obstruction stimulates recruitment of renin-secreting renal cortical cells. Kidney Int 1994;45(5):1333-9.
169. Chung KH, Chevalier RL. Arrested development of the neonatal kidney following chronic ureteral obstruction. J Urol 1996;155(3):1139-44.
170. Cadnapaphornchai P, Bondar NP, McDonald FD. Effect of imidazole on the recovery from bilateral ureteral obstruction in dogs. Am J Physiol 1982;243(12):F532-6.
171. Huguenin M, Ott CE, Romero JC, Knox FG. Influence of renin depletion on renal function- after release of twenty-four hour of ureteral obstruction. J Lab Clin Med 1976:87:57
172. Dzau VJ, Richard RE. Tissue angiotensin system in cardiovascular medicine. A paradigm shift? Circulation 1994;89(l):493-8.
173. Navar LG, Rosivall L. Contribution ofthe renin-angiotensin system to the control of intrarenal hemodynamics. Kidney Int 1984;25:857-68.
174. Hall JE, Brands M W Seidin DW, Giebisch, editors. The Kidney: Physiology and Pathophysiology. 2nd ed. New York: Raven Press, Ltd. 1992; 40,The renin-angiotensin-aldosterone systems. Renal mechanisms and circulatory homeostasis. p. 1455-92.
175. Hall JE, Granger JP. Renal hemodynamic actions of angiotensin II: Interaction with tubuloglomerular feedback. Am J Physiol 1983;245:R166-73.
176. Edwards RM. Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am J Physiol 1983;244:F526-34.
177. Ter Wee PM, Donker AJM. Pharmacologie manipulation of glomerular function. Kidney Int 1994;45:417-24.
178. Blantz RG, Können KS, Tucker BJ. Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest 1976;57:419-34.
179. Meyers BD, DeenWN, Brenner BM. Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule reabsorption in the rat. Circ Res 1975;37:101-10.
180. Carmines PK, Perry MD, Hazelrig JB, Navar LG. Effects of preglomerular and postglomerular vascular resistance alterations on filtration fraction. Kidney Int 1987;31, Suppl. 20:5229-32.
181. Schwietzer G, Laas C, Kampf D, Bahr V, Schultze G, Molzahn M, Distler A. Does captopril reduce renal function in renovascular disease by postglomerular vasodilation? J Hypertens 1985;3(Suppl. 2):S139-41.
182. Steinhausen M, Sterzel RB, Fleming JT, Kühn R,Weis S. Acute and chronic effects of angiotensin II on the vessels of the split hydronephrotic kidney. Kidney Int 1987;31, Suppl.20:S64-73.
183. Taugner R, Hackenthal E, Rix E, Nobiling R, Poulsen K. Immunocytochemistry of the renin-angiotensin system:Renin, angiotensinogen, angiotensin I, angiotensin II, and converting enzyme in the kidneys of mice, rats, and tree shrews. Kidney Int 1982;22, Suppl. 12:833-43.
184. Inagami T, Kawamura M, Naruse K, OkamuraT. Localization of components of the renin-angiotensin system within the kidney. Fed Proc 1986;45(5):1414-9.
185. Inagami T, Mizuno K, Naruse K, OkamuraT, Kawamura M. Intracellular formation and release of angiotensins from juxtaglomerular cells. Kidney Int 1990;38, Suppl. 30:833-7.
186. Mitchell KD, Navar LG. Interactive effects of angiotensin II on renal hemodynamics and tubular reabsorptive function. Kidney Int 1990;38, Suppl. 30:869-73.
187. Rosivall L, Rinder D, Champion J, Khosla MC, Navar LG, Oparil S. Intrarenal angiotensin I conversion at normal and reduced renal blood flow in the dog. Am J Physiol 1983;245:F408-15.
188. Admiraal PJJ, Derkx FHM, Danser AHJ, Pieterman H, Schalekamp ADH. Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 1990;15:44-55.
189. Danser AHJ, Koning MMG, Admiraal PJJ, Sassen LMA, Derkx FHM, Verdouw PD, Schalekamp DH. Production of angiotensin I and II at tissue sites in intact pigs. Am J Physiol 1992;263:H429-37.
190. Rosivall L, Narkates AJ, Oparil S, Navar LG. De novo intrarenal formation of angiotensin II during control and enhanced renin secretion. Am J Physiol 1987;252:F1118-23.
191. Reams G.Villarreal D, Bauer JH. Intrarenal metabolism of angiotensin II. Am J Physiol 1990;258:F1510-5.
192. Gomez RA, Lynch KR, Chevalier RL, Everett AD, Johns DW, Wilfong N, Peach MJ, Carey RM. Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol 1988;254:F900-6.
193. Danser AHJ, et.al. Metabolism of angiotensin I by different tissues in the intact animal. Am J Physiol 1992;263:H418-28.
194. Braam B, Mitchell KD, Fox J, Navar LG. Proximal tubular secretion of angiotensin II in rats. Am J Physiol 1993;264:F891-8.
195. Baylis C, Brenner BM. Modulation by prostaglandin synthesis inhibitors of the action of exogenous angiotensin II on glomerular ultrafiltration in the rat. Circ Res 1978;43:889-98.
196. McGiff JC. Interactions of prostaglandins with the kallikrein-kinin and renin-angiotensin systems. Clin Sei 1980;59:105-16.
197. Baer PG. The contribution of prostaglandins to renal blood flow maintenance is determined by the level of activity of the renin-angiotensin system. Life Sei 1981;28:587-93.
198. Ballermann BJ, Brenner BM. Biologically active atrial peptides. J Clin Invest 1985;76:2041-8.
199. Laragh JH, Atlas SA. Atrial natriuretic hormone: A regulator of blood pressure and volume homeostasis. Kidney Int 1988;34, Suppl 25:S64-71.
200. Gulmi FA, Mooppan UMM, Chou S, Kim H. Atrial natriuretic peptide in patients with obstructive uropathy.JUrol 1989; 142:268-72.
201. Gulmi FA, Matthews GJ, Marion D, Von Lutterotti N, Vaughan ED, Jr.Volume expansion enhances the recovery of renal function and prolonges the diuresis and natriuresis after release of bilateral ureteral obstructions possible role for atrial natriuretic peptide. J Urol 1995;153:1276-83.
202. Chevalier RL.Thornhill BA. Ureteral obstruction in the neonatal guinea
203. Olsen UB,Weis JU, Diness V.Wolffbrandt KH. Atriopeptin III improves renal functions in a ureter-obstructed rat kidney model. Eur J Pharmacol 1986;122(2):191-6.
204. Torikai S. A renorenal suppression in response to atrial natriuretic peptide in the unilateral ischaemic rat. Clin Sei 1988;74:519-25.
205. Laragh J. Atrial natriuretic hormone, the renin-aldosterone axis and blood pressure-electrolyte homeostasis. N Engl J Med 1986;313:1330-40.
206. Mizelle HL, Hildebrandt DA, Gaillard CA, Brands MW, Montani JP, Smith MJ, Jr., Hall JE. Atrial natriuretic peptide induces sustained natriuresis in conscious dogs. Am J Physiol 1990;258(6):R1445-52.
207. Valentin JP, Nafrialdi N, Ribstein J, Mimran A. Endogenous angiotensin II modulates the effect of atrial natriuretic peptide on extracellular fluid partition. Am J Physiol 1993;264(4):R676-80.
208. Mendelsohn FAO, Allan AM, Chai SY, Sexton PM, Figdor R. Overlapping distributions of receptors for atrial natriuretic peptide and angiotensin II visualized by in vitro autoradiography: Morphological basis of physiological antagonism. Can J Physiol Pharmacol 1987;65:1517-21.
209. Bianchi C, Gutkowska J,Thibault G, Garcia R, Genest J, Cantin M. Distinct localization of atrial natriuretic factor and angiotensin II binding sites in the glomerulus. Am J Physiol 1986;251:F594-602.
210. Ballermann BJ, Hoover RL, Karnovsky MJ, Brenner BM. Physiologic regulation of atrial natriuretic peptide receptors in rat renal glomeruli. J Clin Invest 1985;76(6):2049-56.
211. DiBona GF. Prostaglandins and nonsteriodal anti-inflammatory drugs. Am J Med 1986;80, suppl. 1A:12-21.
212. Kramp RA, Genard J, Fourmanoir P, Caron N, Laekeman G, Herman A. Renal hemodynamics and blood flow autoregulation during acute cyclooxygenase inhibition in male rats. Am J Physiol 1995;268:F468-79.
213. Raymond KH, Lifschitz MD. Effect of prostaglandins on renal salt and water excretion. Am J Med 1986;80, suppl. lA:22-33.
214. Nielsen S, Muller J, Knepper M A. Vasopressin- and cAMP-induced changes in ultrastructure of isolated perfused inner medullary collecting ducts. Am J Physiol 1993;265:F225-38.
215. Nielsen S, Chou C, Marples D, Christensen El, Kishore BK, Knepper MA.Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. ProcNatl Acad Sei 1995;92:1013-7.
216. YamamotoT, Sasaki S, Fushimi K, Ishibashi K,Yaoita E, Kawasaki K, Marumo F, Kihara I. Vasopressin increases AQP-CD water channel in apical membrane of collecting duct cells in Brattleboro rats. Am J Physiol 1995;268:C1546-51.
217. Frokiser J, Marples D, Knepper MA, Nielsen S. Bilateral ureteral obstruction downregulates expression of vasopressin-sensitive AQP-2 water channel in rat kidney. Am J Physiol 1996;270:F657-68.
218. Frokir J, Marples D, Monster B, Nielsen UB, Knepper MA, Nielsen S. Downregulation of aquaporin-2 protein and mRNA parallel functional changes of renal water excretion in unilateral obstruction of the ureter. Am J Physiol 1997;273:F213-23.
219. Reyes AA, Robertson G, Klahr S. Role of Vasopressin in rats with bilateral ureteral obstruction. P S E B M 1991;197:49-55.
220. Yamamoto A, Keil LC, Reid IA. Activation of renal mechanoreceptors increases Vasopressin release in rabbits. Am J Physiol 1991;261(2):R484-90.
221. Vaughan ED, Jr., Sweet RE, Gillenwater JY Unilateral ureteral occlusion: Pattern of nephron repair and compensatory response. J Urol 1973;109:979-83.
222. Fransisco LL, Hoversten LG, DiBona GF. Renal nerves in the compensatory adaption to ureteral occlusion. Am J Physiol 1980;238:F229-34.
223. Kopp UC. Renorenal reflexes: neural and functional responses. Federation Proceedings 1985;44:2834-39.
224. Kopp UC, Smith LA, DiBona GF. Renorenal reflexes: neural components of ipsilateral and contralateral renal responses. Am J Physiol 1985;249(4):F507-17.
225. Kopp UC Renorenal reflexes: interaction between efferent and afferent renal nerve activity. Can J Physiol Pharmacol 1992;70(5):750-8.
226. Kopp UC, Smith LA. Inhibitory renorenal reflexes: a role for substance P or other capsaicin-sensitive neurons. Am J Physiol 1991;260(l):R232-9.
227. Kopp UC, Parley DM, Smith LA, Knapp HR. Essential fatty acid deficiency impairs the responsiveness of renal pelvic sensory receptors. Am J Physiol 1995;268(1):R164-70.
228. Kopp UC, Smith LA, Pence AL. Na(+)-K(+)-ATPase inhibition sensitizes renal mechanoreceptors activated by increases in renal pelvic pressure. Am J Physiol 1994;267(4):R1109-17.
229. Kopp UC, Smith LA. Role of prostaglandins in renal sensory receptor activation by substance P and brady' kinin. Am J Physiol 1993;265(3):R544-51.
230. Chevalier RL, Thornhill BA. Ureteral obstruction in the neonatal rat: Renal nerves modulate hemodynamic effects. PediatrNephrol 1995;9:447-50.
231. Ammons WS. Spinoreticular cell responses to renal venous and ureteral occlusion. Am J Physiol 1988;254:R268-76.
232. Kopp UC, Smith LA. Renorenal reflex responses to renal sensory receptor stimulation in normotension and hypertension. Clin Exp Hypertens 1987;A9(Suppl. l):113-25.
233. Kopp UC, Smith LA, DiBona QF. Facilitatory role of efferent renal nerve activity on renal sensory receptors. Am J Physiol 1987;253(4):F767-77.
234. Schubert GE, Staudhammer R, Rolle K, Kneissler U. Tubular dimensions and juxtaglomerular granulation index in rat kidneys after unilateral obstruction of the ureter. Urol Res 1975;3:115-22.
235. Yang HYT, Erdös EG, Levin Y. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta 1970;214:374-6.
236. Williams GH, Hollenberg NK. Accentuated vascular and endocrine response to SQ 20881 in hypertension. N Engl J Med 1977;297:184-8.
237. Mattson DL, Roman RJ. Role of kinins and angiotensin II in the renal hemodynamic response to captopril. Am J Physiol 1991;260(29):F670-9.
238. Kon V, Fogo A, Ichikawa I. Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition. Kidney Int 1993;44:545-50.
239. Campbell DJ, Kladis A, Duncan AM. Bradykinin peptides in kidney, blood, and other tissues of the rat. Hypertension 1993;21:155-65.
240. Fenoy FJ, Scicli G, Carretero O, Roman RJ. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril. Hypertension 1991 ;17:1038-44.
241. El-Dahr SS, Gee J, Dipp S, Hanss BG.Vari RC, Chao J. Upregulation of renin-angiotensin system and downregulation of kallikrein in obstructive nephropathy. Am J Physiol 1993;264:F874-81.
242. Siegel NJ, Upadhyaya K, Kashgarian M. Inhibition by indomethacin of adaptive changes in the contralateral kidney after release of unilateral occlusion. Kidney Int 1981;20:691-4.
243. Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol 1985;249:F324-37.
244. Klahr S, Purkerson ML. The pathophysiology of obstructive nephropathy:The role of vasoactive compounds in the hemodynamic and structural abnormalities of the obstructed kidney. Am J Kidney Dis 1994;23(2):219-223.
245. Hinman F. Renal counterbalance: an experimental and clinical study with reference to the significance of disuse atrophy. J Urol 1923;9:289-314.
246. Fogo A,YoshidaY,Yared A, Ichikawa I. Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys. Kidney Int 1990;38:1068-74.
247. Wolf G, Neilson EG. Angiotensin II as a hypertrophogenic cytokine for proximal tubular cells. Kidney Int 1993;43:100-7.
248. Chung KH, Gomez RA, Chevalier RL. Regulation of renal growth factors and clusterin by ATI receptors during neonatal ureteral obstruction. Am J Physiol 1995;268(6):F1117-23.
249. Tufro-McReddie A, Johns DW, Geary KM, Dagli H, Everett AD, Chevalier RL, Carey RM, Gomez RA. Angiotensin II type i receptor: role in renal growth and gene-expression during normal development. Am J Physiol 1994;266:F911-8.
250. Chevalier RL. Renal responses to ureteral obstruction in early development. Nephron 1990;56:113-7.
251. Yanagisawa H, Morrissey J, Morrison AR, Purkerson ML, Klahr S. Role of ANGII in eicosanoid production by isolated glomeruli from rats with bilateral ureteral obstruction. Am J Physiol 1990;258:F85-93.
252. Frolich JC, Wilson TW, Sweetman BJ, Smigel M, Nies AS, Carr K,Watson JT, Gates JA. Urinary prostaglandins. Identification and origin. J Clin Invest 1975;55:763-70.
253. Yanagisawa H, Morrissey J, Klahr S. Mechanism of enhanced eicosanoid production by isolated glomeruli from rats with bilateral ureteral obstruction. Am J Physiol 1991 ;261:F248-55.
254. Aiken JW.Vane JR. Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J Pharmacol ExpTher 1973;184(3):678-87.
255. Johns EJ, Murdock R, Singer B. The effect of angiotenisn I converting enzyme inhibitor (SQ20881) on the release of prostaglandins by rabbit kidney, in vivo. Br J Pharmac 1977;60:573-81.
256. Hayslett JP. Functional adaptation to reduction in renal mass. Physiol Rev 1979;59(l):137-64.
257. Breyer MD, Badr KF. Brenner BM, editor. The Kidney. 5th ed. Philadelphia: Saunders; 1996; 18, Arachidonic adic metabolites and the kidney, p. 754-88.
258. Kirschner KA. Indomethacin antagonizes furosemides intratubular effects during loop segment microperfusion. J Pharmacol ExpTher 1987;243:881-6.
259. Walker BR. Antidiuresis and decreased sodium excretion during cyclooxygenase inhibition in the conscious dog. Renal Physiol 1983;6:53-62.